This article was originally published Aug. 13.

Helicos BioSciences said last week that it has placed a Helicos Genetic Analysis System at the Massachusetts General Hospital Cancer Center.

The instrument has been installed in the lab of Daniel Haber, who will explore the use of the system for use in characterizing circulating tumor cells, the company said.

Helicos did not disclose the financial terms of the agreement.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.